Insufficient Evidence for Rare Activation of Latent HIV in the Absence of Reservoir-Reducing Interventions. by Alison L Hill, Daniel I S Rosenbloom, Janet D Siliciano, Robert F Siliciano

Get full text

Replicate Testing of Clinical Endpoints Can Prevent No-Go Decisions for Beneficial Vaccines by Daniel I. S. Rosenbloom, Julie Dudášová, Casey Davis, Radha A. Railkar, Nitin Mehrotra, Jeffrey R. Sachs

Get full text

Life cycle synchronization is a viral drug resistance mechanism. by Iulia A Neagu, Jason Olejarz, Mark Freeman, Daniel I S Rosenbloom, Martin A Nowak, Alison L Hill

Get full text

Real-Time Predictions of Reservoir Size and Rebound Time during Antiretroviral Therapy Interruption Trials for HIV. by Alison L Hill, Daniel I S Rosenbloom, Edward Goldstein, Emily Hanhauser, Daniel R Kuritzkes, Robert F Siliciano, Timothy J Henrich

Get full text

Elbasvir/grazoprevir in children aged 3–18 years with chronic HCV genotype 1 or 4 infection: a pharmacokinetic modeling study by Regino P. Gonzalez-Peralta, Stefan Wirth, Robert H. Squires, Frauke Mutschler, Thomas Lang, Malgorzata Pawlowska, Wojciech Sluzewski, Ewa Majda-Stanislawska, Bjorn Fischler, William F. Balistreri, Maureen M. Jonas, Niviann Blondet, Philip Rosenthal, Naim Alkhouri, Rene Romero, Anjana Grandhi, Patricia Castronuovo, Luzelena Caro, Lihong Du, Daniel I.S. Rosenbloom, Barbara A. Haber

Get full text

Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size. by Daniel I S Rosenbloom, Peter Bacchetti, Mars Stone, Xutao Deng, Ronald J Bosch, Douglas D Richman, Janet D Siliciano, John W Mellors, Steven G Deeks, Roger G Ptak, Rebecca Hoh, Sheila M Keating, Melanie Dimapasoc, Marta Massanella, Jun Lai, Michele D Sobolewski, Deanna A Kulpa, Michael P Busch, Reservoir Assay Validation and Evaluation Network (RAVEN) Study Group

Get full text